MedAvail Holdings, Inc. provided revenue guidance for the full year 2022. For the full year 2022, the company expects total revenue for full year 2022 to be at least $42 million, representing growth of at least 90% over full year 2021 revenue.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0003 USD | -.--% | -.--% | -99.99% |
06/05 | Motion for Asset Sale Filed by MedAvail Holdings, Inc. | CI |
03/05 | Notice of Successful Bidder Filed by MedAvail Holdings, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-99.99% | 484 | |
+15.30% | 90.22B | |
+11.48% | 65.95B | |
+13.96% | 36.33B | |
+20.18% | 33.61B | |
+2.11% | 27.14B | |
+7.43% | 26.86B | |
-0.86% | 25.68B | |
+16.54% | 24.91B | |
+3.39% | 22.49B |
- Stock Market
- Equities
- MYOS Stock
- News MedAvail Holdings, Inc.
- MedAvail Holdings, Inc. Provides Revenue Guidance for the Full Year 2022